Review



lactobacillus strains against pathogen bacteria  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    ATCC lactobacillus strains against pathogen bacteria
    (A) Schematic illustration from human subjects. Ulcerative colitis patients (UC, n=35), healthy controls (HC, n=26). (B) Representative endoscopic images. (C) Levels of hemoglobin in the blood. (D-F) Leukocyte (D), monocyte (E) and neutrophil (F) counts in the blood. (G) Principal co-ordinates analysis (PCoA) of unweighted unifrac distance based on the 16S rRNA sequencing from stool samples. ANOSIM (analysis of similarities), R = 0.1, p = 0.007. (H) Linear discriminative analysis (LDA) score of the top 15 most differential genera from HC and UC. (I) Relative abundance of <t>Lactobacillus</t> genus from HC and UC. (J-M) Correlative analysis of Lactobacillus abundance with C-reactive protein (CRP) values (J), leukocyte (K), monocyte (L) and neutrophil (M) counts in UC patients. (N)Venn diagram indicating genus enriched in the stool samples from healthy people and normal mice (LDA score > 3 and p < 0.05 using Wilcoxon rank-sum test). Mean ± SEM shown. ns, not significant, *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001, determined by unpaired Student’s t-test. See also Figure S1, Table S1 and S2.
    Lactobacillus Strains Against Pathogen Bacteria, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 22300 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/lactobacillus+strains+against+pathogen+bacteria/bio_rxiv__2025__09__09__673902-83-5-14?v=ATCC
    Average 99 stars, based on 22300 article reviews
    lactobacillus strains against pathogen bacteria - by Bioz Stars, 2026-07
    99/100 stars

    Images

    1) Product Images from "Enteric ChAT-expressing neurons as new target for Lactobacillus plantarum ameliorates inflammatory bowel diseases"

    Article Title: Enteric ChAT-expressing neurons as new target for Lactobacillus plantarum ameliorates inflammatory bowel diseases

    Journal: bioRxiv

    doi: 10.1101/2025.09.09.673902

    (A) Schematic illustration from human subjects. Ulcerative colitis patients (UC, n=35), healthy controls (HC, n=26). (B) Representative endoscopic images. (C) Levels of hemoglobin in the blood. (D-F) Leukocyte (D), monocyte (E) and neutrophil (F) counts in the blood. (G) Principal co-ordinates analysis (PCoA) of unweighted unifrac distance based on the 16S rRNA sequencing from stool samples. ANOSIM (analysis of similarities), R = 0.1, p = 0.007. (H) Linear discriminative analysis (LDA) score of the top 15 most differential genera from HC and UC. (I) Relative abundance of Lactobacillus genus from HC and UC. (J-M) Correlative analysis of Lactobacillus abundance with C-reactive protein (CRP) values (J), leukocyte (K), monocyte (L) and neutrophil (M) counts in UC patients. (N)Venn diagram indicating genus enriched in the stool samples from healthy people and normal mice (LDA score > 3 and p < 0.05 using Wilcoxon rank-sum test). Mean ± SEM shown. ns, not significant, *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001, determined by unpaired Student’s t-test. See also Figure S1, Table S1 and S2.
    Figure Legend Snippet: (A) Schematic illustration from human subjects. Ulcerative colitis patients (UC, n=35), healthy controls (HC, n=26). (B) Representative endoscopic images. (C) Levels of hemoglobin in the blood. (D-F) Leukocyte (D), monocyte (E) and neutrophil (F) counts in the blood. (G) Principal co-ordinates analysis (PCoA) of unweighted unifrac distance based on the 16S rRNA sequencing from stool samples. ANOSIM (analysis of similarities), R = 0.1, p = 0.007. (H) Linear discriminative analysis (LDA) score of the top 15 most differential genera from HC and UC. (I) Relative abundance of Lactobacillus genus from HC and UC. (J-M) Correlative analysis of Lactobacillus abundance with C-reactive protein (CRP) values (J), leukocyte (K), monocyte (L) and neutrophil (M) counts in UC patients. (N)Venn diagram indicating genus enriched in the stool samples from healthy people and normal mice (LDA score > 3 and p < 0.05 using Wilcoxon rank-sum test). Mean ± SEM shown. ns, not significant, *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001, determined by unpaired Student’s t-test. See also Figure S1, Table S1 and S2.

    Techniques Used: Sequencing

    (A) The abundance of Lactobacillus genus from UC patients in diverse disease course by a previous report. (B) Body weight change. (C) Disease activity index (DAI). (D) Representative image of hematoxylin and eosin (H&E)-staining sections in colon. Scale bar, 50 μm. (E) Histological scores. (F) Principal co-ordinates analysis (PCoA) of stool samples based on unweighted unifrac distances by 16S rRNA sequencing. ANOSIM (analysis of similarities), R = 0.983259, p = 0.001. (G) Averaged relative abundance of bacteria at the genus level from Control and DSS. (H) Linear discriminative analysis (LDA) score of differentially enriched bacterial genera measured by Linear discriminant analysis Effect Size (LEfSe) analysis between Control and DSS. (I) Relative abundance of Lactobacillus genus from Control and DSS in mice. (J-K) Correlation analysis of Lactobacillus abundance with DAI (J) and histological scores (K). Control group (Control, n=8) DSS group (DSS, n=8). Mean ± SEM shown. ns, not significant, *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001, determined by unpaired Student’s t-test.
    Figure Legend Snippet: (A) The abundance of Lactobacillus genus from UC patients in diverse disease course by a previous report. (B) Body weight change. (C) Disease activity index (DAI). (D) Representative image of hematoxylin and eosin (H&E)-staining sections in colon. Scale bar, 50 μm. (E) Histological scores. (F) Principal co-ordinates analysis (PCoA) of stool samples based on unweighted unifrac distances by 16S rRNA sequencing. ANOSIM (analysis of similarities), R = 0.983259, p = 0.001. (G) Averaged relative abundance of bacteria at the genus level from Control and DSS. (H) Linear discriminative analysis (LDA) score of differentially enriched bacterial genera measured by Linear discriminant analysis Effect Size (LEfSe) analysis between Control and DSS. (I) Relative abundance of Lactobacillus genus from Control and DSS in mice. (J-K) Correlation analysis of Lactobacillus abundance with DAI (J) and histological scores (K). Control group (Control, n=8) DSS group (DSS, n=8). Mean ± SEM shown. ns, not significant, *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001, determined by unpaired Student’s t-test.

    Techniques Used: Activity Assay, Staining, Sequencing, Bacteria, Control

    (A-N) Growth curve of L. plantarum (A), L. paracasei (B), L.fermentum (C), L. alimentarius (D), L. brevis (E), L. delbrueckii (F), L.casei (G), L.helveticus (H), L.reuteri (I), L. nagelii (J), L. sakei (K), L.oryzae (L), L.pentosus (M), and L.coryn iformis (N) (n=3). (O) The survival rate of Lactobacillus strains following simulated gastrointestinal fluids. (P) Antibacterial activity. (Q) Diagram of a Caco-2 monolayer. (R) Adhesion of the Lactobacillus strains with Caco-2 cell monolayers (MOE 10, n=3). (S) 4 kDa FITC-dextran paracellular transport from the apical to basolateral compartment on a Caco-2 cell monolayer pretreated with Lactobacillus strains (MOE; 10, 24 h) before TNFα exposure (20 ng/mL, 24 h, n=3). (T) Loading plot of principal component analysis (PCA). (U) Score plot of PCA based on the survival rate, antibacterial activity, adhesion and intestinal permeability of Lactobacillus strains in vitro. (V) Fuzzy synthetic evaluation (FSE) analysis. Mean ± SEM shown. Data are determined by one-way ANOVA with Tukey’s multiple comparison test. ns, not significant, *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001, compared with the Control group, # p<0.05, ## p<0.01, ### p < 0.001, and #### p < 0.0001, compared with the TNFα group.
    Figure Legend Snippet: (A-N) Growth curve of L. plantarum (A), L. paracasei (B), L.fermentum (C), L. alimentarius (D), L. brevis (E), L. delbrueckii (F), L.casei (G), L.helveticus (H), L.reuteri (I), L. nagelii (J), L. sakei (K), L.oryzae (L), L.pentosus (M), and L.coryn iformis (N) (n=3). (O) The survival rate of Lactobacillus strains following simulated gastrointestinal fluids. (P) Antibacterial activity. (Q) Diagram of a Caco-2 monolayer. (R) Adhesion of the Lactobacillus strains with Caco-2 cell monolayers (MOE 10, n=3). (S) 4 kDa FITC-dextran paracellular transport from the apical to basolateral compartment on a Caco-2 cell monolayer pretreated with Lactobacillus strains (MOE; 10, 24 h) before TNFα exposure (20 ng/mL, 24 h, n=3). (T) Loading plot of principal component analysis (PCA). (U) Score plot of PCA based on the survival rate, antibacterial activity, adhesion and intestinal permeability of Lactobacillus strains in vitro. (V) Fuzzy synthetic evaluation (FSE) analysis. Mean ± SEM shown. Data are determined by one-way ANOVA with Tukey’s multiple comparison test. ns, not significant, *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001, compared with the Control group, # p<0.05, ## p<0.01, ### p < 0.001, and #### p < 0.0001, compared with the TNFα group.

    Techniques Used: Activity Assay, Permeability, In Vitro, Comparison, Control

    (A) Experimental diagram for Lactobacillus strains administration schedule. (B) Body weight change (n=8). (C) Body weight change at day 8 after DSS induction (n=8). (D) Disease activity index (DAI) score (n=8). (E) DAI at day 8 after DSS induction (n=8). (F) Representative photographs of colon. (G) Colon length (n=8). (H and I) Representative image of hematoxylin and eosin (H&E)-staining sections in colon and histological scores (n=6). Scale bar, 50 μm. (J-K) Relative gene expression of proinflammatory cytokines including TNF-α (J) and IL-1β (K) in colonic tissues accessed by quantitative real-time PCR. (L-M) AB/PAS staining of the distal colon and elevation of goblet cells per crypt (n=3). Scale bar, 50 μm. (N-O) Representative immunostaining images and quantification of Muc2 in the colon (n=3). Scale bar, 50 μm. (P) Relative gene expression of Muc2 in colonic tissues accessed by quantitative real-time PCR. Data are determined by two-way ANOVA with Tukey’s multiple comparison test (B-E) or one-way ANOVA with Tukey’s multiple comparison test (G-O). ns, not significant, *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001, compared with the Control group, # p<0.05, ## p<0.01, ### p < 0.001, and #### p < 0.0001, compared with the DSS group.
    Figure Legend Snippet: (A) Experimental diagram for Lactobacillus strains administration schedule. (B) Body weight change (n=8). (C) Body weight change at day 8 after DSS induction (n=8). (D) Disease activity index (DAI) score (n=8). (E) DAI at day 8 after DSS induction (n=8). (F) Representative photographs of colon. (G) Colon length (n=8). (H and I) Representative image of hematoxylin and eosin (H&E)-staining sections in colon and histological scores (n=6). Scale bar, 50 μm. (J-K) Relative gene expression of proinflammatory cytokines including TNF-α (J) and IL-1β (K) in colonic tissues accessed by quantitative real-time PCR. (L-M) AB/PAS staining of the distal colon and elevation of goblet cells per crypt (n=3). Scale bar, 50 μm. (N-O) Representative immunostaining images and quantification of Muc2 in the colon (n=3). Scale bar, 50 μm. (P) Relative gene expression of Muc2 in colonic tissues accessed by quantitative real-time PCR. Data are determined by two-way ANOVA with Tukey’s multiple comparison test (B-E) or one-way ANOVA with Tukey’s multiple comparison test (G-O). ns, not significant, *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001, compared with the Control group, # p<0.05, ## p<0.01, ### p < 0.001, and #### p < 0.0001, compared with the DSS group.

    Techniques Used: Activity Assay, Staining, Gene Expression, Real-time Polymerase Chain Reaction, Immunostaining, Comparison, Control



    Similar Products

    99
    ATCC lactobacillus strains against pathogen bacteria
    (A) Schematic illustration from human subjects. Ulcerative colitis patients (UC, n=35), healthy controls (HC, n=26). (B) Representative endoscopic images. (C) Levels of hemoglobin in the blood. (D-F) Leukocyte (D), monocyte (E) and neutrophil (F) counts in the blood. (G) Principal co-ordinates analysis (PCoA) of unweighted unifrac distance based on the 16S rRNA sequencing from stool samples. ANOSIM (analysis of similarities), R = 0.1, p = 0.007. (H) Linear discriminative analysis (LDA) score of the top 15 most differential genera from HC and UC. (I) Relative abundance of <t>Lactobacillus</t> genus from HC and UC. (J-M) Correlative analysis of Lactobacillus abundance with C-reactive protein (CRP) values (J), leukocyte (K), monocyte (L) and neutrophil (M) counts in UC patients. (N)Venn diagram indicating genus enriched in the stool samples from healthy people and normal mice (LDA score > 3 and p < 0.05 using Wilcoxon rank-sum test). Mean ± SEM shown. ns, not significant, *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001, determined by unpaired Student’s t-test. See also Figure S1, Table S1 and S2.
    Lactobacillus Strains Against Pathogen Bacteria, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/lactobacillus+strains+against+pathogen+bacteria/bio_rxiv__2025__09__09__673902-83-5-14?v=ATCC
    Average 99 stars, based on 1 article reviews
    lactobacillus strains against pathogen bacteria - by Bioz Stars, 2026-07
    99/100 stars
      Buy from Supplier

    Image Search Results


    (A) Schematic illustration from human subjects. Ulcerative colitis patients (UC, n=35), healthy controls (HC, n=26). (B) Representative endoscopic images. (C) Levels of hemoglobin in the blood. (D-F) Leukocyte (D), monocyte (E) and neutrophil (F) counts in the blood. (G) Principal co-ordinates analysis (PCoA) of unweighted unifrac distance based on the 16S rRNA sequencing from stool samples. ANOSIM (analysis of similarities), R = 0.1, p = 0.007. (H) Linear discriminative analysis (LDA) score of the top 15 most differential genera from HC and UC. (I) Relative abundance of Lactobacillus genus from HC and UC. (J-M) Correlative analysis of Lactobacillus abundance with C-reactive protein (CRP) values (J), leukocyte (K), monocyte (L) and neutrophil (M) counts in UC patients. (N)Venn diagram indicating genus enriched in the stool samples from healthy people and normal mice (LDA score > 3 and p < 0.05 using Wilcoxon rank-sum test). Mean ± SEM shown. ns, not significant, *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001, determined by unpaired Student’s t-test. See also Figure S1, Table S1 and S2.

    Journal: bioRxiv

    Article Title: Enteric ChAT-expressing neurons as new target for Lactobacillus plantarum ameliorates inflammatory bowel diseases

    doi: 10.1101/2025.09.09.673902

    Figure Lengend Snippet: (A) Schematic illustration from human subjects. Ulcerative colitis patients (UC, n=35), healthy controls (HC, n=26). (B) Representative endoscopic images. (C) Levels of hemoglobin in the blood. (D-F) Leukocyte (D), monocyte (E) and neutrophil (F) counts in the blood. (G) Principal co-ordinates analysis (PCoA) of unweighted unifrac distance based on the 16S rRNA sequencing from stool samples. ANOSIM (analysis of similarities), R = 0.1, p = 0.007. (H) Linear discriminative analysis (LDA) score of the top 15 most differential genera from HC and UC. (I) Relative abundance of Lactobacillus genus from HC and UC. (J-M) Correlative analysis of Lactobacillus abundance with C-reactive protein (CRP) values (J), leukocyte (K), monocyte (L) and neutrophil (M) counts in UC patients. (N)Venn diagram indicating genus enriched in the stool samples from healthy people and normal mice (LDA score > 3 and p < 0.05 using Wilcoxon rank-sum test). Mean ± SEM shown. ns, not significant, *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001, determined by unpaired Student’s t-test. See also Figure S1, Table S1 and S2.

    Article Snippet: For antibacterial activity of the Lactobacillus strains against pathogen bacteria such as Staphylococcus aureus ATCC 6538 and Escherichia coli ATCC 700928, the Oxford cup method was performed according to previous study., Petri plates were poured with sterile Luria Bertani (LB) agar medium and seeded with 200 μL freshly grown pathogen bacteria, followed by wells of 9 mm diameter excavated with a sterilized Oxford cup.

    Techniques: Sequencing

    (A) The abundance of Lactobacillus genus from UC patients in diverse disease course by a previous report. (B) Body weight change. (C) Disease activity index (DAI). (D) Representative image of hematoxylin and eosin (H&E)-staining sections in colon. Scale bar, 50 μm. (E) Histological scores. (F) Principal co-ordinates analysis (PCoA) of stool samples based on unweighted unifrac distances by 16S rRNA sequencing. ANOSIM (analysis of similarities), R = 0.983259, p = 0.001. (G) Averaged relative abundance of bacteria at the genus level from Control and DSS. (H) Linear discriminative analysis (LDA) score of differentially enriched bacterial genera measured by Linear discriminant analysis Effect Size (LEfSe) analysis between Control and DSS. (I) Relative abundance of Lactobacillus genus from Control and DSS in mice. (J-K) Correlation analysis of Lactobacillus abundance with DAI (J) and histological scores (K). Control group (Control, n=8) DSS group (DSS, n=8). Mean ± SEM shown. ns, not significant, *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001, determined by unpaired Student’s t-test.

    Journal: bioRxiv

    Article Title: Enteric ChAT-expressing neurons as new target for Lactobacillus plantarum ameliorates inflammatory bowel diseases

    doi: 10.1101/2025.09.09.673902

    Figure Lengend Snippet: (A) The abundance of Lactobacillus genus from UC patients in diverse disease course by a previous report. (B) Body weight change. (C) Disease activity index (DAI). (D) Representative image of hematoxylin and eosin (H&E)-staining sections in colon. Scale bar, 50 μm. (E) Histological scores. (F) Principal co-ordinates analysis (PCoA) of stool samples based on unweighted unifrac distances by 16S rRNA sequencing. ANOSIM (analysis of similarities), R = 0.983259, p = 0.001. (G) Averaged relative abundance of bacteria at the genus level from Control and DSS. (H) Linear discriminative analysis (LDA) score of differentially enriched bacterial genera measured by Linear discriminant analysis Effect Size (LEfSe) analysis between Control and DSS. (I) Relative abundance of Lactobacillus genus from Control and DSS in mice. (J-K) Correlation analysis of Lactobacillus abundance with DAI (J) and histological scores (K). Control group (Control, n=8) DSS group (DSS, n=8). Mean ± SEM shown. ns, not significant, *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001, determined by unpaired Student’s t-test.

    Article Snippet: For antibacterial activity of the Lactobacillus strains against pathogen bacteria such as Staphylococcus aureus ATCC 6538 and Escherichia coli ATCC 700928, the Oxford cup method was performed according to previous study., Petri plates were poured with sterile Luria Bertani (LB) agar medium and seeded with 200 μL freshly grown pathogen bacteria, followed by wells of 9 mm diameter excavated with a sterilized Oxford cup.

    Techniques: Activity Assay, Staining, Sequencing, Bacteria, Control

    (A-N) Growth curve of L. plantarum (A), L. paracasei (B), L.fermentum (C), L. alimentarius (D), L. brevis (E), L. delbrueckii (F), L.casei (G), L.helveticus (H), L.reuteri (I), L. nagelii (J), L. sakei (K), L.oryzae (L), L.pentosus (M), and L.coryn iformis (N) (n=3). (O) The survival rate of Lactobacillus strains following simulated gastrointestinal fluids. (P) Antibacterial activity. (Q) Diagram of a Caco-2 monolayer. (R) Adhesion of the Lactobacillus strains with Caco-2 cell monolayers (MOE 10, n=3). (S) 4 kDa FITC-dextran paracellular transport from the apical to basolateral compartment on a Caco-2 cell monolayer pretreated with Lactobacillus strains (MOE; 10, 24 h) before TNFα exposure (20 ng/mL, 24 h, n=3). (T) Loading plot of principal component analysis (PCA). (U) Score plot of PCA based on the survival rate, antibacterial activity, adhesion and intestinal permeability of Lactobacillus strains in vitro. (V) Fuzzy synthetic evaluation (FSE) analysis. Mean ± SEM shown. Data are determined by one-way ANOVA with Tukey’s multiple comparison test. ns, not significant, *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001, compared with the Control group, # p<0.05, ## p<0.01, ### p < 0.001, and #### p < 0.0001, compared with the TNFα group.

    Journal: bioRxiv

    Article Title: Enteric ChAT-expressing neurons as new target for Lactobacillus plantarum ameliorates inflammatory bowel diseases

    doi: 10.1101/2025.09.09.673902

    Figure Lengend Snippet: (A-N) Growth curve of L. plantarum (A), L. paracasei (B), L.fermentum (C), L. alimentarius (D), L. brevis (E), L. delbrueckii (F), L.casei (G), L.helveticus (H), L.reuteri (I), L. nagelii (J), L. sakei (K), L.oryzae (L), L.pentosus (M), and L.coryn iformis (N) (n=3). (O) The survival rate of Lactobacillus strains following simulated gastrointestinal fluids. (P) Antibacterial activity. (Q) Diagram of a Caco-2 monolayer. (R) Adhesion of the Lactobacillus strains with Caco-2 cell monolayers (MOE 10, n=3). (S) 4 kDa FITC-dextran paracellular transport from the apical to basolateral compartment on a Caco-2 cell monolayer pretreated with Lactobacillus strains (MOE; 10, 24 h) before TNFα exposure (20 ng/mL, 24 h, n=3). (T) Loading plot of principal component analysis (PCA). (U) Score plot of PCA based on the survival rate, antibacterial activity, adhesion and intestinal permeability of Lactobacillus strains in vitro. (V) Fuzzy synthetic evaluation (FSE) analysis. Mean ± SEM shown. Data are determined by one-way ANOVA with Tukey’s multiple comparison test. ns, not significant, *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001, compared with the Control group, # p<0.05, ## p<0.01, ### p < 0.001, and #### p < 0.0001, compared with the TNFα group.

    Article Snippet: For antibacterial activity of the Lactobacillus strains against pathogen bacteria such as Staphylococcus aureus ATCC 6538 and Escherichia coli ATCC 700928, the Oxford cup method was performed according to previous study., Petri plates were poured with sterile Luria Bertani (LB) agar medium and seeded with 200 μL freshly grown pathogen bacteria, followed by wells of 9 mm diameter excavated with a sterilized Oxford cup.

    Techniques: Activity Assay, Permeability, In Vitro, Comparison, Control

    (A) Experimental diagram for Lactobacillus strains administration schedule. (B) Body weight change (n=8). (C) Body weight change at day 8 after DSS induction (n=8). (D) Disease activity index (DAI) score (n=8). (E) DAI at day 8 after DSS induction (n=8). (F) Representative photographs of colon. (G) Colon length (n=8). (H and I) Representative image of hematoxylin and eosin (H&E)-staining sections in colon and histological scores (n=6). Scale bar, 50 μm. (J-K) Relative gene expression of proinflammatory cytokines including TNF-α (J) and IL-1β (K) in colonic tissues accessed by quantitative real-time PCR. (L-M) AB/PAS staining of the distal colon and elevation of goblet cells per crypt (n=3). Scale bar, 50 μm. (N-O) Representative immunostaining images and quantification of Muc2 in the colon (n=3). Scale bar, 50 μm. (P) Relative gene expression of Muc2 in colonic tissues accessed by quantitative real-time PCR. Data are determined by two-way ANOVA with Tukey’s multiple comparison test (B-E) or one-way ANOVA with Tukey’s multiple comparison test (G-O). ns, not significant, *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001, compared with the Control group, # p<0.05, ## p<0.01, ### p < 0.001, and #### p < 0.0001, compared with the DSS group.

    Journal: bioRxiv

    Article Title: Enteric ChAT-expressing neurons as new target for Lactobacillus plantarum ameliorates inflammatory bowel diseases

    doi: 10.1101/2025.09.09.673902

    Figure Lengend Snippet: (A) Experimental diagram for Lactobacillus strains administration schedule. (B) Body weight change (n=8). (C) Body weight change at day 8 after DSS induction (n=8). (D) Disease activity index (DAI) score (n=8). (E) DAI at day 8 after DSS induction (n=8). (F) Representative photographs of colon. (G) Colon length (n=8). (H and I) Representative image of hematoxylin and eosin (H&E)-staining sections in colon and histological scores (n=6). Scale bar, 50 μm. (J-K) Relative gene expression of proinflammatory cytokines including TNF-α (J) and IL-1β (K) in colonic tissues accessed by quantitative real-time PCR. (L-M) AB/PAS staining of the distal colon and elevation of goblet cells per crypt (n=3). Scale bar, 50 μm. (N-O) Representative immunostaining images and quantification of Muc2 in the colon (n=3). Scale bar, 50 μm. (P) Relative gene expression of Muc2 in colonic tissues accessed by quantitative real-time PCR. Data are determined by two-way ANOVA with Tukey’s multiple comparison test (B-E) or one-way ANOVA with Tukey’s multiple comparison test (G-O). ns, not significant, *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001, compared with the Control group, # p<0.05, ## p<0.01, ### p < 0.001, and #### p < 0.0001, compared with the DSS group.

    Article Snippet: For antibacterial activity of the Lactobacillus strains against pathogen bacteria such as Staphylococcus aureus ATCC 6538 and Escherichia coli ATCC 700928, the Oxford cup method was performed according to previous study., Petri plates were poured with sterile Luria Bertani (LB) agar medium and seeded with 200 μL freshly grown pathogen bacteria, followed by wells of 9 mm diameter excavated with a sterilized Oxford cup.

    Techniques: Activity Assay, Staining, Gene Expression, Real-time Polymerase Chain Reaction, Immunostaining, Comparison, Control